Install
Find clear answers fast
Search focused on FAQs
4FAQ is a purpose-built search engine for FAQ content. It indexes support pages, help centers, knowledge bases, product QandA, and community answers. The platform combines multiple indexes and AI systems to prioritize concise question-and-answer pairs, highlight official guidance, and reduce time to resolution. Use 4FAQ to find clear steps, policy details, and product support information across the web. Part of the 4SEARCH network of topic specific search engines.
Latest Articles
Notice - PETER MICHAEL DEEB and CANADIAN INVESTMENT REGULATORY ORGANIZATION and ONTARIO SECURITIES COMMISSION, File No. 2026-10
13+ hour, 10+ min ago (78+ words) The Globe and Mail Notice - PETER MICHAEL DEEB and CANADIAN INVESTMENT REGULATORY ORGANIZATION and ONTARIO SECURITIES COMMISSION, File No. 2026-10 TORONTO, Sept. 9, 2026 /CNW/ -- The case management hearing in the above-named proceeding scheduled for September 14, 2026, at 10:00 a.m. will not proceed as scheduled. All…...
Levi & Korsinsky Reminds Regeneron Pharmaceuticals Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 14, 2026 - REGN
15+ hour, 30+ min ago (518+ words) NEW YORK, Sept. 9, 2026 Institutional investors with REGN positions may need to assess alleged clinical-trial disclosure failures that preceded a $102.09 per-share decline from the Class Period high. This notice focuses on fiduciary review, portfolio loss documentation, and lead plaintiff considerations. REGN…...
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28 Deadline
12+ hour, 37+ min ago (330+ words) Sep 09, 2026, 17:02 ET Hagens Berman encourages investors in Capricor Therapeutics, Inc. (NASDAQ: CAPR) who suffered substantial losses to submit your losses now. FDA Extends BLA Review Following Post-AdCom Submissions On Aug. 24, Capricor announced that the FDA has extended the Prescription Drug…...
HDB INVESTOR DEADLINE: HDFC Bank Limited Investors with Substantial Losses Have Opportunity to Lead the HDFC Shareholder Class Action Lawsuit Before October 13, 2023
12+ hour, 32+ min ago (311+ words) Sep 09, 2026, 17:07 ET SAN FRANCISCO, Sept. 9, 2026 /PRNewswire/ -- Hagens Berman, a national law firm noted for its preeminent work in securities class action litigation, notifies investors in HDFC Bank Limited (NYSE: HDB) of a pending securities fraud class action. HDFC Bank Limited…...
On Demand: Billy Loughnane - Mercantile - Kempton
16+ hour, 39+ min ago (20+ words) Racing TV Oh no! It looks like JavaScript is not enabled in your browser....
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 13, 2026 in The Simply Good Foods Company Lawsuit - SMPL
13+ hour, 30+ min ago (646+ words) NEW YORK, Sept. 9, 2026 A securities class action alleges Simply Good Foods' former CEO Geoff E. Tanner and CFOs Shaun P. Mara and Christopher J. Bealer certified filings that painted the $280 million OWYN integration as on track, while SMPL shareholders absorbed a decline of…...
BABA INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
1+ day, 11+ hour ago (115+ words) San Francisco, California--(Newsfile Corp. - September 8, 2026) - Hagens Berman Sobol Shapiro LLP urges Alibaba Group Holding Limited (NYSE:......
CAPR INVESTOR DEADLINE: Capricor Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before September 28, 2026 Deadline
1+ day, 11+ hour ago (39+ words) San Francisco, California--(Newsfile Corp. - September 8, 2026) - Hagens Berman Sobol Shapiro LLP-a national plaintiffs' rights law firm with......
INVESTOR ALERT: The M&A Class Action Firm Launches Investigation of the Merger - AUUD, TECH, CZR and CBAN
1+ day, 20+ hour ago (312+ words) PR Newswire NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class…...
MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law
1+ day, 21+ hour ago (175+ words) Published on 09/08/2026 at 08:09 am EDT If you suffered substantial losses and wish to serve as lead plaintiff of the Regeneronclass action lawsuit, please provide your information here: You can also contact attorneys Ken Dolitsky or Michael Albert of Robbins Geller…...